Standpoint Research Upgrades McKesson (MCK) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
Deutsche Bank Downgrades McKesson (MCK) to Hold
October 28, 2016 7:17 AM EDTDeutsche Bank downgraded McKesson (NYSE: MCK) from Buy to Hold with a price target of $153.00 (from $196.00). Analyst George Hill expressed fears of a price war in drug wholesaling.
"MCK reported F2Q results below consensus, but it was the company's outlook and... More
Leerink Partners Downgrades McKesson (MCK) to Market Perform
October 28, 2016 7:08 AM EDTLeerink Partners downgraded McKesson (NYSE: MCK) from Outperform to Market Perform with a price target of $160.00.
Analyst David Larsen commented, "MCK reported F2Q:17 adjusted EPS of $2.94 (-11% y/y) which was well below Leerink/Consensus of $3.10/$3.04. Management also reduced F2017 EPS... More
McKesson (MCK) Misses Q2 EPS by 11c; Updates FY17 EPS Outlook
October 27, 2016 4:14 PM EDTMcKesson (NYSE: MCK) reported Q2 EPS of $2.94, $0.11 worse than the analyst estimate of $3.05. Revenue for the quarter came in at $50 billion versus the consensus estimate of $51.21 billion.
GUIDANCE:
McKesson sees FY2017 EPS of $12.35-$12.85, versus the consensus of $13.59.
For earnings history and earnings-related data on McKesson (MCK) click here.
... More